Europe’s pharma industry risks lagging behind US and China, says German drugmaker
Boehringer Ingelheim says pricing regime hinders access to treatments as group touts liver benefits from weight-loss drug
Related reading
Europe is risking ‘health sovereignty’ by underpaying for drugs, says…
CEO warns continent’s advantage in the industry could fade as companies build new high-tech factories elsewhere
Pharma just ‘scratching the surface’ of weight-loss drug market
Novo Nordisk chief estimates industry reaching only 15% of potential customers at most
US drugmakers threaten to withhold products from Europe over prices
Pharmaceutical companies seek to make up any lost revenue after striking deals with Donald Trump to lower costs in US
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
EU trims exclusivity window for new drugs
Cheaper generics will be allowed on to market a year earlier to curb costs